Sodium n-butyrate enhancement of prostaglandin D2 antitumor efficacy.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002087:Butyrates / Q000627:therapeutic use*; D020148:Butyric Acid; D002460:Cell Line; D002470:Cell Survival; D004341:Drug Evaluation; D004357:Drug Synergism; D005260:Female; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011457:Prostaglandins D / Q000627:therapeutic use*; D011458:Prostaglandins E / Q000627:therapeutic use
D000970:Antineoplastic Agents; D002087:Butyrates; D011457:Prostaglandins D; D011458:Prostaglandins E; D020148:Butyric Acid